98473912
Mar 28, 2024
Financial services, namely, financing services related to intellectual property portfolios; Financial services, namely, financing services for pharmaceutical, drug, and medical device development; Financial services, namely, providing working capital to others by monetizing royalty streams and acquiring revenue interests relating to the sale of products; Financial services, namely, providing venture capital, development capital, private equity and investment funding through debt-like structures, the development and commercialization of products; Financial services, namely, providing non-dilutive capital to counterparties, including through the purchase of revenue interests and the use of debt-like structures; Equity capital investment
Insurance and Financiallicensing of intellectual property; Product licensing services, namely licensing of pharmaceutical, biopharmaceutical and chemical technology products being medicines
Personal